Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
Conditions:   Medullary Thyroid Carcinoma;   Multiple Endocrine Neoplasia Type 2A;   Multiple Endocrine Neoplasia Type 2BIntervention:   Drug: VandetanibSponsors:   National Cancer Institute (NCI);   National Institutes of Health Clinical Center (CC)Active, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2007 Category: Research Source Type: clinical trials

Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes
Condition:   Multiple Endocrine NeoplasiaIntervention:   Behavioral: QuestionnaireSponsor:   M.D. Anderson Cancer CenterActive, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2007 Category: Research Source Type: clinical trials

Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
Conditions:   Multiple Endocrine Neoplasia;   Recurrent Thyroid Cancer;   Thyroid Gland Medullary CarcinomaInterventions:   Drug: sorafenib tosylate;   Other: pharmacological study;   Other: laboratory biomarker analysisSponsor:   National Cancer Institute (NCI)Active, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2006 Category: Research Source Type: clinical trials